Global Leaders Watch TrumpXi Summit for Trade and Economic Signals Nvidias Blockbuster Quarter Reveals 200 Billion Opportunity and Edge Computing Potential Amid China Market Shift BP Shares Dip as Board Removes Chairman Albert Manifold Over Conduct Concerns Treasury Yield Surge Challenges RiskFree Status Opens Doors in Credit Markets Euphoria Season 3 Death Scene Potentially Reshapes Storyline and Viewer Engagement Baiya Renames Crypto Strategy After Receiving 1 Million BNB Allocation MLEC Q2 2025 Earnings Narrower Loss than Expected as Stock Rises ASR Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds VICI Properties Q1 2026 Earnings Strong EPS Beat Driven by Resilient Portfolio Performance American Rebel Holdings Inc AREB Q1 2026 Earnings Significant Net Loss Amid Lack of Revenue Ellington Credit Company EARN Q2 2025 Earnings EPS Misses Estimates as Credit Market Challenges Persist American Rebel Holdings Inc AREB Q1 2026 Earnings Significant Net Loss Amid Lack of Revenue Titan America SA TTAM Holds Steady as Support and Resistance Define a Tight Range Dr Reddys Laboratories RDY Slips 124 as Stock Tests Key Support Levels SouthState Bank SSB Holds Near Support as Bank Sector Faces Mixed Signals Corcept Therapeutics CORT Edges Higher as Stock Stabilizes Near Key Support Civeo Corporation CVEO Declines 163 as Support Levels Come into Focus Essential Properties Realty Trust Inc EPRT Q1 2026 Earnings EPS Miss Amidst Steady Portfolio Performance PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline Unity Software U Q1 2026 Earnings Narrower Loss Per Share Exceeds Expectations SCSC Q1 2026 Earnings Marginal EPS Miss Amidst Operational Stability RPT Q1 2026 Earnings Net Loss Exceeds Expectations as Real Estate Headwinds Persist Amplitech Group Inc Series B Right AMPGZ Q1 2026 Earnings EPS Misses Estimates on Wide Surprise Stock Drops Over 18 B Riley Raises Price Target on Silicon Motion Signaling Optimism NTGR Q1 2026 Earnings EPS Returns to Profitability with 268 Surprise AEON Biopharma Dips 274 as Stock Nears Critical Support at 076